Germany pauses anti-malaria drug study for COVID-19: Spiegel

Reuters

28 May 2020 0 shares 1 views

Germany pauses anti-malaria drug study for COVID-19: Spiegel

Germany pauses anti-malaria drug study for COVID-19: Spiegel

Reuters

Published 28 May 2020

A university in Germany has suspended a clinical study using the anti-malaria drug hydroxychloroquine for COVID-19, Spiegel Online reported on Thursday, after the World Health Organisation decided this week to pause a large trial over safety concerns.

You might like

Related news coverage

Germany pauses anti-malaria drug study for COVID-19

Germany pauses anti-malaria drug study for COVID-19

Jerusalem Post 28 May 2020

Several European governments moved on Wednesday to halt the use of the anti-malaria drug to treat COVID-19 patients, and a second..

Cyprus curtails use of chloroquine over side-effect concerns
SeattlePI.com 28 May 2020
Coronavirus outbreak: WHO warns of COVID-19 'second peak' as lockdowns ease
Mid-Day 26 May 2020
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors 26 May 2020
UN virus therapy trial pauses hydroxychloroquine testing
SeattlePI.com 25 May 2020

Advertisement

More coverage

Study Shows COVID-19 Patients Did Not Benefit From Hydroxycholoroquine

Study Shows COVID-19 Patients Did Not Benefit From Hydroxycholoroquine

Newsy 12 May 2020

Watch VideoA new study found patients hospitalized in the New York metro area did not benefit from being prescribed the..

Anti-malarial drug taken by Donald Trump linked to death risk
SBS 22 May 2020
Trump Defends His Use Of Hydroxychloroquine
Eurasia Review 20 May 2020
President Trump Says He Is Taking Hydroxychloroquine
Newsy 19 May 2020
Coronavirus: what’s happening in the labs of pharma companies worldwide
Proactive Investors 14 May 2020